2007-05-08
big pharma
Another weblog has been brought to my attention exposing another BigPharma cover up: GSK: License to Kill. That's GlaxoSmithKline, and in Great Britain they have been involved with suppression of information about their drug Seroxat, rather like Eli Lilly's cover up efforts with Zyprexa.
The premise behind the blog is as follows:
Another weblog has been brought to my attention exposing another BigPharma cover up: GSK: License to Kill. That's GlaxoSmithKline, and in Great Britain they have been involved with suppression of information about their drug Seroxat, rather like Eli Lilly's cover up efforts with Zyprexa. The premise behind the blog is as follows:
I am going to focus on adult suicidality from Seroxat in this post. It is clear from the information in the previous posts how GSK hoodwinked the regulators for a licence to treat adults with Seroxat from 1991 onwards. They tried desperately to push for a licence to treat children with Seroxat as this would have increased its marketing profile, but they failed miserably. Also we can see from the previous links, that Seroxat clearly posed a danger to children and in the end GSK failed to prove the benefits outweighed the risks. The questions I want to ask here though are concerned with Seroxat use in the adult populations. If Seroxat greatly increases the risk of suicide, aggression and hostility in children with depression and other disorders then why wouldn’t it be the same for adults? No Doctor, psychiatrist or expert has ever been able to explain to me why the effects of Seroxat would be any different between a child or adolescent or an adult taking the drug. Why does GSK maintain that Seroxat is safe for use in the adult populations? when even they themselves admit that it can cause severe and dangerous side effects in children?Check out his findings. ¶ 12:59
